Biofarm S.A. (BVB:BIO)

Market Cap	827.71M
Revenue (ttm)	308.52M
Net Income (ttm)	81.22M
Shares Out	985.37M
EPS (ttm)	0.07
PE Ratio	11.22
Forward PE	n/a
Dividend	0.03 (3.72%)
Ex-Dividend Date	Aug 18, 2025

Volume	72,672
Average Volume	101,115
Open	0.8340
Previous Close	0.8340
Day's Range	0.8300 - 0.8460
52-Week Range	0.6200 - 0.8980
Beta	0.35
RSI	41.58
Earnings Date	Aug 14, 2025

About Biofarm

Biofarm S.A. manufactures and sells medicines in Romania. The company offers a portfolio of products covering therapeutic areas, such as antiallergics, cardiovascular and circulatory, analgesics and antipyretics, dermatology, digestive and metabolic, endocrine, genitourinary, multivitamins, ophthalmology, musculoskeletal, respiratory and ENT, and neurology. It provides prescription and non-prescription medicines, food supplements, medical devices, cosmetics, and other products. The company also exports its products in Azerbaijan, Albania, Georg...

• Industry: Pharmaceutical Preparations
• Founded: 1921
• Employees: 373
• Stock Exchange: Bucharest Stock Exchange
• Ticker Symbol: BIO

Financial Performance

In 2024, Biofarm's revenue was 286.77 million, an increase of 2.31% compared to the previous year's 280.29 million. Earnings were 74.40 million, a decrease of -3.40%.